EUVIMEDEUVIMED entdecken
Crossref

Chronochimiothérapie à base de 5-fluorouracil, acide folinique et oxaliplatine administrée en deux jours toutes les deux semaines pour le cancer colorectal. L’expérience du CHC-Liège (Belgique)

C Focan, G Demolin, F Kreutz, M-P Graas, L Longrée, G Matus, N Moeneclaey, D Focan-Henrard

Pathologie Biologie · 2013-10 · 61 (5) · e71-e74

DOI: 10.1016/j.patbio.2011.02.002 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Pathologie Biologie, 2013-10. Verfasst von C Focan und 7 weiteren Autor:innen. Beteiligte Einrichtung: CHC-Liège, Clinique Saint-Joseph, rue de Hesbaye 75, 4000 Liège, France. Electronic address: christian.focan@chc.be. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 22 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

One hundred and ten consecutive patients suffering from a colorectal cancer received chronotherapy infused over two days every two weeks. Each course comported 5 FU 3g/m(2), folinic acid (600 mg/m(2) - l. form or 1200 mg/m(2)--racemic form) and oxaliplatin (85/mg/m(2)--adjuvant indication or 100mg/m(2)--palliative indication). According to chronobiological concepts, 5 FU and folinic acid were infused from 10 pm to 10 am with a peak at 4 am while oxaliplatin was delivered from 10 am to 10 pm with a peak at 4 pm. The overall tolerance was excellent with a maximum of 17% patients experiencing a grade 3 toxicity. The toxicity was higher in women, in older patients (>=70) or in case of flat infusion. In adjuvant situation (60 cases), progression free and overall survivals established respectively at 76% (42+months) and 88% (45+months). Fifty-two percent response rate were recorded within the palliative group (50 cases) with an overall 68% disease control. Median progression free survival was seven months but median survival was not attained at 31+ months. Thirty percent patients could benefit from a curative surgery after chemotherapy. Older patients (>=70) experienced worsened survival. In conclusion, we think that our chrono-FOLFOX 2-12 should be proposed as standard treatment for colorectal cancer patients.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

AgedAged, 80 and overAntineoplastic Combined Chemotherapy ProtocolsChronotherapyColorectal NeoplasmsFemaleFluorouracilHumansLeucovorinMaleMiddle AgedOrganoplatinum CompoundsOxaliplatinSurvival RateTreatment Outcome

Stichwörter der Autor:innen

Cancer colorectalChronotherapyChronothérapieColorectal cancerOxaliplatinOxaliplatine

Substanzen

Organoplatinum CompoundsOxaliplatinLeucovorinFluorouracil

Autor:innen und Institutionen

  • CHC-Liège, Clinique Saint-Joseph, rue de Hesbaye 75, 4000 Liège, France. Electronic address: christian.focan@chc.be.

Zitieren

APA

Focan, C., Demolin, G., Kreutz, F., Graas, M. P., Longrée, L., Matus, G., Moeneclaey, N., & Focan-Henrard, D. (2013). Chronochimiothérapie à base de 5-fluorouracil, acide folinique et oxaliplatine administrée en deux jours toutes les deux semaines pour le cancer colorectal. L’expérience du CHC-Liège (Belgique). Pathologie Biologie, 61(5), e71-e74. https://doi.org/10.1016/j.patbio.2011.02.002

Vancouver

Focan C, Demolin G, Kreutz F, Graas MP, Longrée L, Matus G, et al. Chronochimiothérapie à base de 5-fluorouracil, acide folinique et oxaliplatine administrée en deux jours toutes les deux semaines pour le cancer colorectal. L’expérience du CHC-Liège (Belgique). Pathologie Biologie. 2013;61(5):e71-e74. doi:10.1016/j.patbio.2011.02.002

BibTeX
@article{Focan2013,
  author = {Focan, C and Demolin, G and Kreutz, F and Graas, M-P and Longrée, L and Matus, G and Moeneclaey, N and Focan-Henrard, D},
  title = {Chronochimiothérapie à base de 5-fluorouracil, acide folinique et oxaliplatine administrée en deux jours toutes les deux semaines pour le cancer colorectal. L’expérience du CHC-Liège (Belgique)},
  journal = {Pathologie Biologie},
  year = {2013},
  volume = {61},
  number = {5},
  pages = {e71--e74},
  doi = {10.1016/j.patbio.2011.02.002}
}
Kostenlos starten →